Our data demonstrated greater levels of CD147 glycosylation in obese T2D subjects compared to other groups (~1-fold (p = 0.036) and 1.9 folds (p = 0.003) higher than obese non-diabetic subjects and controls, respectively) (Figure 1C,D). The gene discussed is BSG; the disease is type 2 diabetes mellitus.